Butylated Hydroxyanisole (BHA); Request for Information
FDA requests information on BHA uses and safety in human food and food contact substances, potentially affecting dietary supplement labeling and ingredient compliance.
Aforeworn detected this change in the Dietary-Supplement Labeling (FDA) space on July 5, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Supplement brands, contract manufacturers, private-label sellers, ingredient suppliers using BHA in dietary supplements or food contact materials. should confirm how it applies to their specific situation before acting. There is a time constraint attached: May 12, 2026 (90 days after publication on Feb 11, 2026).. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Dietary-Supplement Labeling (FDA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
FDA issued a Request for Information (RFI) on current uses and safety data of BHA, signaling potential future regulatory changes.
Who it affects
Supplement brands, contract manufacturers, private-label sellers, ingredient suppliers using BHA in dietary supplements or food contact materials.
What you must do
Submit information on BHA uses and safety data to FDA by the deadline.
Deadline
May 12, 2026 (90 days after publication on Feb 11, 2026).
Never miss a change like this again
Aforeworn watches Dietary-Supplement Labeling (FDA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trial